# Fresenius Kabi USA, LLC - Inspection Records Source: https://www.keypedia.com/companies/fresenius-kabi-usa-llc/f0c47fa1-3b76-4e6c-82dd-d703086bdfdc > Inspection records and compliance data for Fresenius Kabi USA, LLC in Grand Island, New York. Access full analysis and detailed observations. --- ## Details - Name: Fresenius Kabi USA, LLC - FEI Number: 3001833549 - City: Grand Island - State: New York - Country Name: United States - Address Line 1: 3159 Staley Rd - Zip Code: 14072 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE ## Related Documents - [483 - Fresenius Kabi USA, LLC - 2026-05-14](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/48b37132-1acd-44cc-84d6-ca784a5d2932) — source: FDA, date: May 14, 2026 - [483 - Fresenius Kabi USA, LLC - 2023-10-13](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/475fcb6e-dfe5-45dd-991c-a9313ad63c64) — source: FDA, date: October 13, 2023 - [FDA Inspection 1220482 - Fresenius Kabi USA, LLC - 2023-10-13](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/a88e316f-f4c4-4146-b519-14affbebe818) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 13, 2023 - [483 - Fresenius Kabi USA, LLC - 2023-08-30](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/91efc984-74c0-4435-9a5c-15f4efbc26a7) — source: FDA, date: August 30, 2023 - [FDA Inspection 1216357 - Fresenius Kabi USA, LLC - 2023-08-30](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/6b172d0c-ba88-4cda-9500-e353ae9c96c7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 30, 2023 - [FDA Inspection 1216357 - Fresenius Kabi USA, LLC - 2023-08-30](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/7f0cd17c-920d-421e-8b7c-c5256d920e67) — classification: No Action Indicated (NAI), source: FDA, date: August 30, 2023 - [EIR - Fresenius Kabi USA, LLC - 2019-08-12](https://www.keypedia.com/records/eir/fresenius-kabi-usa-llc/87921e70-5047-4e61-8a13-363df2771de2) — source: FDA, date: August 12, 2019 - [483 - Fresenius Kabi USA, LLC - 2019-08-12](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/90344142-2ce1-4a03-96d2-df8dfafa023e) — source: FDA, date: August 12, 2019 - [FDA Inspection 1099323 - Fresenius Kabi USA, LLC - 2019-08-12](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/df38d6b1-2a83-4f94-b26f-c9cd94982cd7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2019 - [483 - Fresenius Kabi USA, LLC - 2018-06-29](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/073d0262-f2d1-4776-9be6-655e8bbf723d) — source: FDA, date: June 29, 2018 - [EIR - Fresenius Kabi USA, LLC - 2017-03-30](https://www.keypedia.com/records/eir/fresenius-kabi-usa-llc/4bd5e3cf-07a2-4d22-91e3-3a14bb95780e) — source: FDA, date: March 30, 2017 - [483 - Fresenius Kabi USA, LLC - 2017-03-30](https://www.keypedia.com/records/483/fresenius-kabi-usa-llc/463f9a6a-44e5-45a6-8b51-d075f7bf4476) — source: FDA, date: March 30, 2017 - [FDA Inspection 1014707 - Fresenius Kabi USA, LLC - 2017-03-30](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/27fb2ee2-a807-46e7-8155-c4a761f3b2e1) — classification: No Action Indicated (NAI), source: FDA, date: March 30, 2017 - [FDA Inspection 1014707 - Fresenius Kabi USA, LLC - 2017-03-30](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/fa80ae85-8005-43d6-9e43-13e92aa608d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 30, 2017 - [EIR - Fresenius Kabi USA, LLC - 2017-02-01](https://www.keypedia.com/records/eir/fresenius-kabi-usa-llc/81749a45-4ec6-4fb2-bb3c-acccfda81673) — source: FDA, date: February 1, 2017 - [FDA Inspection 1002820 - Fresenius Kabi USA, LLC - 2017-02-01](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/252f9abd-eb39-4e89-a14e-68bb888a36c1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2017 - [EIR - Fresenius Kabi USA, LLC - 2016-02-04](https://www.keypedia.com/records/eir/fresenius-kabi-usa-llc/7bfacb1b-a38d-47fb-8b98-934a7b7fcc1e) — source: FDA, date: February 4, 2016 - [FDA Inspection 962308 - Fresenius Kabi USA, LLC - 2016-02-04](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/6e9fb937-55f5-4054-923c-bc884ae55733) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 4, 2016 - [FDA Inspection 901775 - Fresenius Kabi USA, LLC - 2014-10-24](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/338bfa08-73cf-419a-a687-b12adcba504e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 24, 2014 - [FDA Inspection 901775 - Fresenius Kabi USA, LLC - 2014-10-24](https://www.keypedia.com/records/fda_inspections/fresenius-kabi-usa-llc/d1d6cd6a-a864-4fe6-9ef7-bcd0769b86d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 24, 2014 ## Related Companies - [Bioreliance Ltd.](https://www.keypedia.com/companies/bioreliance-ltd/fec1a160-db6a-4ebc-9632-aa6e2996e17e) - [Pyramid Laboratories, Inc.](https://www.keypedia.com/companies/pyramid-laboratories-inc/28e777be-a530-400a-97c6-9780ede4fb33) - [Valneva Scotland Ltd.](https://www.keypedia.com/companies/valneva-scotland-ltd/7e6970c2-c9dd-4c5d-9d35-725121b6e877) - [Lonza Bend Inc.](https://www.keypedia.com/companies/lonza-bend-inc/35de45c5-ab00-4ab8-a472-a01f6edc8897) - [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/97a7893d-fd4c-45bc-9237-0e03e7d8af7c) - [COSMETIC LABORATORY INC](https://www.keypedia.com/companies/cosmetic-laboratory-inc/f3977335-f446-489a-be98-aa03c573776b) - [United Therapeutic Corporation](https://www.keypedia.com/companies/united-therapeutic-corporation/fda8d6ce-d684-4496-89b6-5f8b526d83f7) - [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/1c40f7df-1e2e-48cb-b768-ad55e472ad64) - [Cardinal Health 414, LLC](https://www.keypedia.com/companies/cardinal-health-414-llc/b1d6d59b-695c-42a4-8272-d3e5a96de306) - [Prothya Biosolutions Belgium](https://www.keypedia.com/companies/prothya-biosolutions-belgium/14cc76aa-03ad-49c2-aec8-4af088fd986a) ## Related Officers - [Charanjeet Jassal](https://www.keypedia.com/people/charanjeet-jassal/85aad819-fe9c-41dd-8280-23bcbeb8826c) - [Patric C. Klotzbuecher](https://www.keypedia.com/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e) - [issuing_officer](https://www.keypedia.com/people/erika-englund/13d235ca-da4b-40e3-add0-c62372c8c25e) - [Mandy Chan](https://www.keypedia.com/people/mandy-chan/437eb591-92d9-49ac-943c-33c7584c0b89) - [Consumer Safety Officer Drug Specialist](https://www.keypedia.com/people/sony-mathews/4d42379f-1245-494c-8c19-6cefa4e560a5) - [James D. Bridges](https://www.keypedia.com/people/james-d-bridges/8ce30e52-4b32-4d12-84a2-b2a9ce8f6f53)